Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

University of Khartoum

ClinicalTrials.gov lists University of Khartoum as lead sponsor of 14 trials. It has 10 active development programs and 15 approved assets.

SD Academic
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

3 0 2008 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers University of Khartoum: 14 lead-sponsored trials and 1 legal-entity registration.

Get the University of Khartoum report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (44)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Malaria 7
Insulin Resistance 2
Kidney Failure, Chronic 2
Leishmaniasis, Visceral 2
Renal Insufficiency, Chronic 2

Showing 5 of 44 disease areas.

Start your 14-day trial Email me all 44 disease areas as a PDF

Trials by start year as sponsor or collaborator (14)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2022 3
2021 1
2020 2
2019 2
2018 2
2017 3
2016 2
2015 1
2013 2
2012 1

Showing 10 of 14 years.

Start your 14-day trial Email me all 14 years as a PDF

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Active development programs (10)

Shown in this order: max phase, then active trials.

Active development programs
Drug Disease area Max phase Trials
Diclofenac Pain Phase 2 1
Diclofenac Postoperative Pain Phase 2 1
Acetaminophen Pain Phase 2 1
Acetaminophen Postoperative Pain Phase 2 1
Mefenamic Acid Pain Phase 2 1

Showing 5 of 10 active programs.

Start your 14-day trial Email me all 10 active programs as a PDF

Approved assets (15)

Shown in this order: max phase first.

Approved assets
Drug Trials
Interleukin 2 Receptor Antagonist 1
Antithymocyte Immunoglobulin (Rabbit) 1
Artemether + Lumefantrine 1
Artesunate 1
Dihydroartemisinin + Piperaquine (Artekin) 1

Showing 5 of 15 approved assets.

Start your 14-day trial Email me all 15 approved assets as a PDF

Journals published in (22)

Shown in this order: most published in first.

Journals published in
Journal Publications
Journal of endodontics 3
Malaria journal 3
BMC hematology 2
BMC research notes 2
Transactions of the Royal Society of Tropical Medicine and Hygiene 2

Showing 5 of 22 journals.

Start your 14-day trial Email me all 22 journals as a PDF

Organization relationships (21)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
University of York Co sponsors trial with 3
Foundation for Innovative New Diagnostics, Switzerland Co sponsors trial with 2
Eijkman Institute for Molecular Biology Co sponsors trial with 2
University of Kassala, Sudan Co sponsors trial with 2
European & Developing Countries Clinical Trials Partnership Co sponsors trial with 1

Showing 5 of 21 relationships.

Start your 14-day trial Email me all 21 relationships as a PDF

Latest dated events (24)

Shown in this order: newest first.

Latest dated events
Date Event Source
2022-11-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2022-06-30 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2022-05-22 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2021-12-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2020-06-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 24 events.

Start your 14-day trial Email me all 24 events as a PDF

Biomarker capability evidence (2)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
PKD2L1 Trial collaborator Named in trial inclusion criteria
PKD2L1 Trial collaborator Mentioned in trial text

Biomarkers this organization publishes on (79)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
IL10 5
SLC17A5 5
IFNG 4
TNF 4
ALB 3

Showing 5 of 79 biomarkers.

Start your 14-day trial Email me the first 50 biomarkers as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.